Assembled from the company's filings and exchange data as of today. Download PDF renders this page on the server; the narrative sections arrive with the Nexa composer.
Dossier · Vaxfab Enterprises Limited · 7 November 2026Page 1 of 3
Company Dossier
MarketPing Research · factual · no rating expressed
Vaxfab Enterprises Limited
BSE: 542803
BSE: 542803
Services › Services › Commercial Services & Supplies › Trading & Distributors
Vaxfab Enterprises Limited
StateQ1 FY27 filed
Last close · 6 Nov 2026₹67.85
Market cap₹0.1k cr
TTM P/E · P/B · EV/EBITDA15.3 · 1.31 · —
Vaxfab Enterprises Limited is a Commercial Services & Supplies company. The annual-report business brief for this company has not been generated yet; the numbers below are as filed.
What a broker report prints here — the analyst's thesis. This dossier prints the filed record instead; the narrative read of the latest results, the guidance ledger and the earnings-call summary are the composer's sections (INSTITUTIONAL-PLAN.md M3) and are not yet produced.
Exhibit 1: Financial summary, FY23–FY26 (all audited; no estimate years)
| ₹ crore · consolidated | FY23 | FY26 |
|---|---|---|
| Revenue | 17 | 131 |
| EBITDA (ex other income) | 0 | (9) |
| margin % | 2.7 | (6.5) |
| Owners' profit | 0 | (5) |
| EPS, as reported (₹) | 1.98 | (0.55) |
| ROE % · ROCE % | 2.4 · 2.7 | (10.6) · (7.1) |
| Debt / equity (x) | 0.02 | 1.02 |
| Cash from operations | 2 | — |
| Capex | 0 | — |
Source: SEBI results XBRL as filed with BSE/NSE; EBITDA excludes other income.
Every figure is a filed number or a ratio over filed numbers · No rating, target or fair value is expressed · Disclosures on the last pagemarketping.in
Dossier · Vaxfab Enterprises Limited · 7 November 2026Page 2 of 3
Exhibit 2: Quarterly performance, last 5 quarters
| ₹ crore | Q4 FY23 | Q1 FY24 | Q3 FY26 | Q4 FY26 | Q1 FY27 |
|---|---|---|---|---|---|
| Revenue | 14 | 4 | 16 | 46 | 0 |
| Profit before tax | 0 | 0 | 0 | 4 | (2) |
| Net profit | 0 | 0 | 0 | 2 | (3) |
| EPS (₹) | 1.41 | 0.31 | 0.27 | 0.26 | 3.61 |
Source: quarterly results as filed; the balance sheet is filed half-yearly and is not repeated here.
Exhibit 3: Peers — basic industry group, by market cap
| Company | M.cap ₹ cr | P/E | P/B | EV/EBITDA | ROE % | ROCE % | Rev CAGR 5y % | EBITDA m. % |
|---|---|---|---|---|---|---|---|---|
| REDINGTON LIMITED | 25,680 | 13.8 | 2.36 | 12.2 | 8.0 | 10.8 | 15.9 | 2.0 |
| MMTC LIMITED | 8,018 | 17.9 | 3.78 | — | 18.3 | 21.6 | (83.7) | (2969.1) |
| MSTC LIMITED | 4,160 | 17.8 | 4.60 | 16.7 | 24.2 | 31.8 | (13.9) | 61.3 |
| CREATIVE NEWTECH LIMITED | 1,993 | 28.0 | 4.64 | 26.8 | 9.2 | 10.3 | — | 5.0 |
| Pervasive Commodities Limited | 1,182 | 77.2 | 13.13 | — | 0.0 | 0.0 | — | 1.9 |
| The Yamuna Syndicate Ltd | 774 | 8.5 | 0.60 | 508.1 | 4.0 | 0.3 | 4.8 | 3.4 |
| SHIV AUM STEELS LIMITED | 748 | 65.8 | 6.19 | 54.1 | 6.0 | 6.9 | — | 4.7 |
| THE STATE TRADING CORPN | 624 | 0.9 | — | — | — | — | — | — |
Source: exchange data and filed statements via the screener; multiples at current prices.
Exhibit 4: Where the company sits in its group
| Metric | Company | Group median | Rank | Better than |
|---|---|---|---|---|
| P/E (TTM) | 15.3 | 14.7 | 69 of 132 | 48% |
| P/B | 1.3 | 0.9 | 87 of 151 | 42% |
| ROCE | (7.1) | 1.6 | 158 of 175 | 10% |
| ROE | (10.6) | 2.0 | 141 of 158 | 11% |
| Debt / Equity | 1.0 | 0.1 | 134 of 156 | 14% |
| EBITDA margin | (1412.1) | 2.3 | 145 of 146 | 1% |
| Revenue growth | (97.2) | (8.6) | 124 of 135 | 8% |
| Profit growth | (1191.5) | 1.7 | 156 of 160 | 3% |
| Market cap | 57 | 21 | 53 of 178 | 71% |
Source: MarketPing peer ranks; a rank is a measurement, not a view.
Every figure is a filed number or a ratio over filed numbers · No rating, target or fair value is expressed · Disclosures on the last pagemarketping.in
Dossier · Vaxfab Enterprises Limited · 7 November 2026Page 3 of 3
Exhibit 5: Filings of the last 90 days, with the measured price reaction
| Date · filing | Category | Importance | Next day % | 5-day % |
|---|---|---|---|---|
| 3 Nov 2026 · Independent forensic audit appointed for FY2022-23 through FY2024-25 | regulatory legal | high | — | — |
| 16 Oct 2026 · New Company Secretary appointed, previous CS resigns at Vaxfab Enterprises | management changes | medium | — | — |
| 7 Oct 2026 · Compliance certificate under SEBI Reg 74(5) for Q2 FY27 | compliance | minimal | — | — |
| 1 Oct 2026 · Board approves rights issue to raise up to Rs. 45 crore | fund raising | medium | — | — |
| 1 Oct 2026 · Board approves Rs 45 crore Rights Issue of equity shares | board shareholder meetings | low | — | — |
| 30 Sept 2026 · All 4 resolutions passed at Vaxfab 43rd AGM on 29 Sep 2026 | board shareholder meetings | low | — | — |
| 29 Sept 2026 · 43rd AGM held; share capital hike approved, auditor and MD reappointed | board shareholder meetings | low | — | — |
| 28 Sept 2026 · Trading window closed from Oct 1, 2026 for Q2 results | compliance | minimal | — | — |
| 25 Sept 2026 · Board meeting on Oct 1 to consider fund raising via equity and other securities | board shareholder meetings | low | — | — |
| 9 Sept 2026 · Notice of 43rd AGM published in newspapers | compliance | minimal | — | — |
Source: exchange announcements; each reaction is measured from the close before the filing. Next day = the close one session after the reaction day (the first session that could trade the filing).
How to read this document
| Where a broker report shows | This document shows | Why |
|---|---|---|
| A rating (BUY / ADD / REDUCE / SELL) | A state: the latest filed quarter and the measured reactions | an event is a fact; a rating is an opinion that requires SEBI RA registration |
| A target price and upside | The current price and the multiples against the group | a target is a forecast; a multiple is a measurement |
| Estimate years marked E | More audited years; no estimates | MarketPing publishes no forecasts — your own model lives on the Models page |
Sources, method and disclosures
This document is a statistical summary of publicly filed information and market data, prepared by software from primary sources: SEBI results XBRL filed with BSE and NSE, LODR disclosures, shareholding patterns, exchange price data. It contains no research recommendation, no price target and no opinion on the merits of any security, and is not a research report within the meaning of the SEBI (Research Analysts) Regulations, 2014, Regulation 2(1)(w)(vii). Financial statements are as filed (consolidated where the company files consolidated results). Ratios are computed over filed lines. Where a figure is unavailable the table shows a dash rather than an estimate. The business brief is written by MarketPing's reader from the annual report and checked against it; no figure in a table was generated by a model. Nothing here constitutes investment advice, an offer or a solicitation; readers should consult a SEBI-registered adviser before acting. MarketPing is not a SEBI-registered intermediary.
Every figure is a filed number or a ratio over filed numbers · No rating, target or fair value is expressed · Disclosures on the last pagemarketping.in